Proteomic aging clocks in epidemiological studies: advances, applications and prospects
- 20 May 2026
- journal article
- review article
- Published by Springer Nature in Nature Aging
- Vol. 6 (5) , 970-986
Abstract
Biological age may provide a more informative metric of individual physiological function and life expectancy, compared to chronological age. Proteomic aging clocks are predictive models trained using high-dimensional proteomic data to quantify biological age. Owing to the central biological role of proteins and their established clinical utility as druggable targets and prognostic biomarkers, proteomics is particularly promising for the assessment of aging. In this Review, we provide an overview of current proteomic clocks based on different platforms in human blood samples, emphasizing their potential clinical application as discovery, predictive and response aging biomarkers. While the field is advancing rapidly, proteomic clocks vary widely in their assay platforms, study populations and modeling strategies, which may limit their generalizability, biological interpretability and translational utility. We further discuss current challenges and prospects in this research area, which aims to facilitate the implementation of proteomic clocks in proactive, preventive medicine to extend population healthspan.Keywords
Funding Information
- UKRI Future Leaders Fellowship
- Imperial College London President's PhD Scholarships
- UKRI Future Leaders Fellowship
This publication has 191 references indexed in Scilit:
- Gompertz Law‐Based Biological Age (GOLD BioAge): A Simple and Practical Measurement of Biological Ageing to Capture Morbidity and Mortality RisksAdvanced Science, 2025
- The AccelerAge framework: a new statistical approach to predict biological age based on time-to-event dataEuropean Journal of Epidemiology, 2024
- Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular EventsJAMA, 2023
- Pro‐Inflammatory Proteins Associated with Frailty and Its Progression—A Longitudinal Study in Community‐Dwelling WomenJournal of Bone and Mineral Research, 2023
- Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatmentMolecular Oncology, 2023
- Biological Age Acceleration and Motoric Cognitive Risk SyndromeAnnals of Neurology, 2023
- The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trialGeroScience, 2022
- Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platformsProteomics, 2022
- Assessment of Advanced Glycation End Products and Receptors and the Risk of DementiaJAMA Network Open, 2021
- Satellite cell‐specific ablation of Cdon impairs integrin activation, FGF signalling, and muscle regenerationJournal of Cachexia, Sarcopenia and Muscle, 2020